Eric Edwards

Dr. Eric Edwards is Co-Founder and CEO of Phlow Corp., a pioneering public benefit pharmaceutical corporation. As CEO, Dr. Edwards is committed to providing a solution to the broken essential medicines supply chain and over-reliance on foreign manufacturers for our nation’s highest priority medicines.

Dr. Edwards was previously co-founder of Kaléo, Inc. a pharmaceutical company. During his 16 years at Kaléo, he held several executive management positions including: Chief Science Officer, overseeing scientific strategy and all pharmaceutical development programs; Chief Medical Officer, responsible for developing a medical affairs team and capability while operationalizing the company’s clinical program strategy; and Vice President – Innovation, guiding Kaleo’s research and development pipeline and overall new product strategy.

Dr. Edwards is the co-inventor of multiple marketed products, including AUVI-Q, an epinephrine auto-injector for the treatment of allergic/anaphylaxis emergencies; is named on over 215 issued and patent-pending applications; and is a published author on numerous scientific publications.

Since 1999, he has been a volunteer paramedic for a local rescue squad, including responding to 911 calls and training paramedics in pre-hospital emergency care. He also serves on the boards of Lighthouse Labs and Activation Capital.

Dr. Edwards. obtained his B.S. in Biology, Ph.D. in the Pharmaceutical Sciences, and Doctor of Medicine degrees at Virginia Commonwealth University/Medical College of Virginia.